首页> 外国专利> Chromene and 1,1a, 2,7b - tetrahidrociclopropa c chromene piridopirazinadionas as modulators of g-secretase

Chromene and 1,1a, 2,7b - tetrahidrociclopropa c chromene piridopirazinadionas as modulators of g-secretase

机译:Chromene和1,1a,2,7b-四氢环丙醇[c]色烯吡啶并吡嗪并吡喃酮作为g-分泌酶的调节剂

摘要

The related drug components and their use in the treatment of neurodegenerative diseases are also described. Claim 1: a compound (1) having a formula structure,Or a pharmaceutically acceptable salt, wherein: a selects (2) a (5) from the formula compound group;X is heteroaryl (5 to 14 members) containing 1-3 heteroatoms; R¹ is selected from the group consisting of hydrogen, halogen, cyano, hydroxy, C₁₋₆ alkyl,C₁₋₆ alkoxy,C₃₋₈ cycloalkyl and C₂₋₆ alkenyl;where the C₁₋₆ alkyl,C₁₋₆ alkoxy,C₃₋₈ cycloalkyl and C₂₋₆ alkenyl are optionally substituted with one to three substituents each independently selected from the group consisting of fluorine, hydroxy and C₁₋₆ alkoxy;7491 and 7495;In each case, the group consisting of hydrogen, fluorine, cyanogen, hydroxy and hydrocarbyl c833136 is selected independently;C₁₋₆ alkoxy,alcoxi C alquilo CC₁₋₆ hydroxyalkyl,C₁₋₆ haloalkyl,C₂₋₆ alkenyl,1. C 83228331 asphae. Cycloquilo c8322338s and phenyl; alquenilo c83228331;1. C 83228331 asphaC₃₋₈ cycloalkyl and phenyl are optionally substituted with one to three substituents each independently selected from the group consisting of cyano, hydroxy, C₁₋₃ alkyl,C₁₋₃ hydroxyalkyl and fluorine; or R²ᵃ and R²ᵇ together with the carbon atoms to which they bind form a C₃₋₈ cycloalkyl or a (4 to 10 membered) heterocycloalkyl,wherein the C₃₋₈ cycloalkyl and the (4 to 10 membered) heterocycloalkyl are optionally substituted with one to three R⁸;R8308;]C₁₋₆ alkoxy and C₁₋₆alkoxy C₁₋₆,where the C₁₋₆ alkyl,alcoxi C o alcoxi C alquilo Cthey are optionally substituted with one to three substituents independently selected from the group consisting of cyano, hydroxy and fluorine; or R⁴ᵃ and R⁴ᵇ together with the carbon atom to which they form form a C₃₋₈ cycloalkyl,wherein the C₃₋₈ cycloalkyl is optionally substituted with one to three substituents each independently selected from the group consisting of cyano, fluorine, hydroxy, C₁₋₆ alkyl,C₁₋₆ alkoxy,alcoxi C alquilo CC₁₋₆ hydroxyalkyl,a. Halide c83218c831832626;R8309;; 74919 and r8309;; 74955;at each occurrence, they are independently selected from the group consisting of hydrogen, hydroxy, C₁₋₆ alkyl,C₁₋₆ alkoxy,and C₁₋₆alkyl C₁₋₆alkoxy,where the C₁₋₆ alkyl,C₁₋₆ alkoxy,or C₁₋₆alkyl C₁₋₆alkoxy,they are optionally substituted with one to three substituents each independently selected from the group consisting of cyano, hydroxy and fluorine; or R⁵ᵃ and R⁵ᵇ together with the carbon atoms to which they are attached form a C₃₋₈ cycloalkyl wherein the C₃₋₈ cycloalkyl is optionally substituted with one to three substituents each independently selected from the group consisting of cyano, fluorine, hydroxy , C₁₋₆ alkyl,C₁₋₆ alkoxy,alcoxi C alquilo CC₁₋₆ hydroxyalkyl,a. Halide c83218c831832626;R⁶ and R⁷ are each independently selected from the group consisting of hydrogen, cyano, halogen, C₁₋₆ alkyl,C₁₋₆ hydroxyalkyl,C₁₋₆ alkoxy,alcoxi C alquilo CAnd halide c83218c831832626,Y-Or8313;The condition is that r8310 and r8311 cannot be two kinds of hydrogen Xi; r831222;at each occurrence, it is independently selected from the group consisting of cyano, halogen, hydroxy, C₁₋₆ alkyl,C₁₋₆ alkoxy,alcoxi C alquilo Ce. Hydroxialquilo c83216c8318326 and halogeoquilo c833213126;R⁹ is selected from the group consisting of hydrogen and C₁₋₆ alkyl;wherein the C₁₋₆ alkyl is optionally substituted with one to three substituents each independently selected from the group consisting of cyano, hydroxy and fluorine; z is an integer selected from 1 or 2; and is an integer selected from 1, 2, 3 or 4; the wavy line is a bond that connects to any carbon atom in ring B or ring C that is chemically permissible; m is an integer selected from 1, 2, 3 or 4; n is an integer selected from 0 or 1; W is carbon or oxygen; Ring B is optionally substituted with up to five R¹⁰,wherein each R¹⁰ is independently selected from the group consisting of halogen, cyano. hydroxy, C₁₋₆ alkyl,C₁₋₆ hydroxyalkyl,C₁₋₆ alkoxy,alcoxi C alquilo CC₁₋₆ haloalkyl,C₁₋₆ haloalkoxy,1. C8332121 aspha-SF₅ and C₃₋₆ cycloalkyl,wherein the C₃₋₆ cycloalkyl is optionally substituted with up to three substituents independently selected from the group consisting of halogen, hydroxy, C₁₋₆ alkyl,C₁₋₆ hydroxyalkyl,C₁₋₆ alkoxy,alcoxi C alquilo CC₁₋₆ haloalkyl,and C₁₋₆ haloalkoxy;or two R¹⁰ substituents taken together with the carbon atoms to which they are attached form a C₃₋₆ terminal cycloalkyl which is optionally substituted with one to three substituents independently selected from the group consisting of halogen, hydroxy, C₁₋₆ alkyl,C₁₋₆ hydroxyalkyl,C₁₋₆ alkoxy,alcoxi C alquilo CC₁₋₆ haloalkyl and C₁₋₆ haloalkoxy;Ring C is optionally substituted with up to four R¹¹ such that the substitution occurs in any carbon atom that is chemically permissible, and wherein each R¹¹ is independently selected from the group consisting of halogen, cyano, hydroxy, C₁₋ alkyl ₆,C₁₋₆ hydroxyalkyl,C₁₋₆ alkoxy,alcoxi C alquilo CC₁₋₆ haloalkyl,C₁₋₆ haloalkoxy,1. C8332121 aspha-SF832525,C₃₋₆ cycloalkyl,And straight propylene (4-6 members)wherein the C₃₋₆ cycloalkyl and the heterocycloalkyl portions (4 to 6 members) are optionally substituted with up to three halogens, hydroxy, C₁₋₆ alkyl,C₁₋₆ alkoxy,C₁₋₆alkoxyC alcoalkyl or hydroxyalkylC₁₋₆;or two R¹¹ taken together with the carbon atoms to which they bind form a C₃₋₆ cycloalkyl or a heterocycloalkyl (from 4 to 6 members) in which the C₃₋₆ cycloalkyl and portions of heterocycloalkyl (from 4 to 6 members) each is optionally substituted with one to three substituents independently selected from the group consisting of halogen, hydroxy, C₁₋₆ alkyl,C₁₋₆ hydroxyalkyl,C₁₋₆ alkoxy,alcoxi C alquilo CC₁₋₆ haloalkyl,and C₁₋₆ haloalkoxy;Ring D is optional up to 4.1km,R2 is independent of the group composed of halogen, cyanogen, hydroxyl and c832131 asphaC₁₋₆ hydroxyalkyl,C₁₋₆ alkoxy,alcoxi C alquilo CC₁₋₆ haloalkyl,C₁₋₆ haloalkoxy. Cilt alkylthio,-SF₅. C₃₋₆ cycloalkyl and heterocycloalkyl (4 to 6 members),wherein the C₃₋₆ cycloalkyl and the heterocycloalkyl (4 to 6 members) are optionally substituted with one to three substituents independently selected from the group consisting of halogen, hydroxy, C₁₋₆ alkyl,C₁₋₆ hydroxyalkyl,C₁₋₆ alkoxy,alcoxi C alquilo CC₁₋₆ haloalkyl,and C₁₋₆ haloalkoxy;This is a double or simple link.
机译:还描述了相关的药物成分及其在神经退行性疾病治疗中的用途。 2.权利要求1的具有式结构的化合物(1)或其药学上可接受的盐,其中:a选自式化合物组中的(2)a(5); X为含有1-3个杂原子的杂芳基(5至14个成员) ; R 1选自氢,卤素,氰基,羟基,C 1-4烷基,C 1-4烷氧基,C 1-6环烷基和C 2-4烯基;其中C 1-6烷基,C 1-4烷氧基,C 1-4。环烷基和C 1-6烯基任选地被1-3个取代基取代,每个取代基独立地选自氟,羟基和C 1-4烷氧基; 7491和7495;在每种情况下,由氢,氟,氰,羟基和烃基c833136是独立选择的; C 1烷氧基,烷氧基C alquilo C 1羟烷基,C 4卤代烷基,C 2-8烯基,1。 C 83228331沥青; e。环喹啉c8322338s和苯基; alquenilo c83228331; 1。 C 83228331沥青; C 1-3环烷基和苯基任选被1-3个取代基取代,每个取代基独立地选自氰基,羟基,C 1-4烷基,C 1-6羟基烷基和氟;或R 20和R 20与它们所键合的碳原子一起形成C 1-7环烷基或(4-10元)杂环烷基,其中所述C 5-6环烷基和(4-10元)杂环烷基任选地被一个或多个环取代。 3个R 3; R 8308;] C 6烷氧基和C 3烷氧基C 8,其中C 1烷基,烷氧基C o烷氧基C alquilo Cthey任选地被1-3个独立地选自氰基,羟基的取代基取代和氟;或R 5和R 6与它们形成的碳原子一起形成C 1-7环烷基,其中C 1-7环烷基任选地被1-3个取代基取代,每个取代基独立地选自氰基,氟,羟基,C 4-8 ₆烷基,C₁₋₆烷氧基,醇C C基CC₁₋₆羟烷基,a。卤化物c83218c831832626; R8309 ;; 74919和r8309 ;; 74955;每次出现时,它们独立地选自氢,羟基,C 1-4烷基,C 1-4烷氧基和C 1-4烷基C 1-4烷氧基,其中C 1-6烷基,C 1-4烷氧基或C 1 -C 6烷氧基,它们任选地被1-3个取代基取代,每个取代基独立地选自氰基,羟基和氟;或R 5和R 6与它们所连接的碳原子一起形成C 1-7环烷基,其中C 1-7环烷基任选地被1-3个取代基取代,每个取代基独立地选自氰基,氟,羟基,C 4-8 ₆烷基,C₁₋₆烷氧基,醇C C基CC₁₋₆羟烷基,a。卤化物c83218c831832626; R 5和R 6各自独立地选自氢,氰基,卤素,C 1-8烷基,C 4羟烷基,C 4烷氧基,醇Calquilo C和卤化物c83218c831832626,Y-Or8313;条件为r8310和r8311不能是两种氢Xi;在每次出现时,它独立地选自氰基,卤素,羟基,C 1-4烷基,C 1-4烷氧基,alcoxi C alquilo Ce。羟基喹啉基c83216c8318326和卤代喹啉基c833213126; R 5选自氢和C 1-4烷基;其中C 1-6烷基任选被1-3个取代基取代,每个取代基独立地选自氰基,羟基和氟。 z是选自1或2的整数;并且是选自1、2、3或4的整数;波浪线是连接到化学上允许的环B或环C中任何碳原子的键; m是选自1、2、3或4的整数; n是选自0或1的整数; W是碳或氧; B环任选被至多五个R 15取代,其中每个R 15独立地选自卤素,氰基。羟基,C 1-4烷基,C 1-6羟基烷基,C 1-4烷氧基,醇C 1quilo C 1-4卤代烷基,C 1-4卤代烷氧基,1。 C8332121沥青; -SF 3和C 6环烷基,其中C 3环烷基任选被至多三个独立地选自卤素,羟基,C 4烷基,C 4羟烷基,C 4烷氧基的取代基取代,C 1-8烷基,C 1-8烷基,C 1-8卤代烷氧基,或C 1-8卤代烷氧基;或两个R 17取代基与它们所连接的碳原子一起形成C 1末端环烷基,其任选地被1-3个独立地选自以下的取代基取代:基团由卤素,羟基,C 1-4烷基,C 1-4羟烷基,C 1-4烷氧基,醇氧基C alquilo C 1-4卤代烷基和C 1-4卤代烷氧基组成;环C可选地被至多四个R 1-1取代,从而发生取代在化学上允许的任何碳原子中,并且每个R 11独立地选自卤素,氰基,羟基,C 1-8烷基,C 1羟烷基,C 1烷氧基,烷氧基C aquilo CC 8卤代烷基, C 1卤代烷氧基,1。 C8332121沥青; -SF832525,C 1-7环烷基和直链丙烯(4-6个成员),其中C 3-6环烷基和杂环烷基部分(4-6个成员)任选地被最多三个卤素,羟基,C 1-8烷基,C 5-8取代烷氧基,C 1-8烷氧基C 1烷基烷基或羟烷基C 1;或两个R 11与它们所结合的碳原子一起形成C 1环烷基或杂环烷基(4至6个成员),其中C 4环烷基和部分杂环烷基(4至6个成员)各自任选地被1-3个独立地选自卤素,羟基,C 1-4烷基,C 1-6羟基烷基,C 1-4烷氧基,烷氧基C aquilo CC卤代烷基的取代基取代; C卤代烷氧基; D环长达4.1 km是可选的,R 2不依赖于卤素,氰,羟基和c832131沥青; C 1-6羟烷基,C 1-4烷氧基,醇C ,C 1卤代烷氧基。甲硫基-SF 3。 C 6环烷基和杂环烷基(4至6元),其中C 1环烷基和杂环烷基(4至6元)任选地被1-3个独立地选自卤素,羟基,C 4的取代基取代烷基,C 1-4羟烷基,C 1-4烷氧基,烷氧基C alquilo C 1-4卤代烷基和C 1-4卤代烷氧基;这是双或简单的连接。

著录项

  • 公开/公告号AR099874A1

    专利类型

  • 公开/公告日2016-08-24

    原文格式PDF

  • 申请/专利权人 PFIZER INC.;

    申请/专利号AR2015P100922

  • 发明设计人

    申请日2015-03-27

  • 分类号C07D471/04;A61K31/4985;A61P25/28;

  • 国家 AR

  • 入库时间 2022-08-21 14:27:36

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号